For Floridians, 2024 was a year of weight loss and emerging revelations about anti-obesity medications.

Weight loss injections have become a popular solution for individuals seeking medical assistance to achieve their weight ...

Experts recommend 5 peptide-based medications for weight loss, such as liraglutide and semaglutide. They require medical ...

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies to produce Victoza, also known as liraglutide, following a proposal by the ...

with the potential for a 15% weight loss after 68 weeks in adults with a BMI of 30 or greater [1]. Like Ozempic, Wegovy is also prescription only and taken once a week. Saxenda, like Ozempic and ...

Like Ozempic and Saxenda, some doctors may prescribe this medication off-label for weight loss support. The manufacturer’s website states that although it is not a weight loss drug, people can ...

A new weight loss treatment known as tripeptide (Mounjaro) is expected to be rolled out via the NHS in March 2025 ...

Saxenda is covered by many insurances and is available on the NHS. In the UK, it is prescribed via specialist NHS weight-loss services for people with a BMI of 35 or above, who have prediabetes ...

Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

The anti-obesity drug Zepbound made by Eli Lilly & Co. could be one of the biggest cost drivers for health insurers and ...